Country-level corruption and accounting choice: Research & development capitalization under IFRS

被引:24
|
作者
Mazzi, Francesco [1 ]
Slack, Richard [2 ]
Tsalavoutas, Ioannis [3 ]
Tsoligkas, Fanis [4 ]
机构
[1] Univ Florence, Econ & Management Sch, Accounting & Finance Div, Via Pangette 9,Bldg D6, I-50127 Florence, Italy
[2] Univ Durham, Business Sch, Mill Hill Lane, Durham DH1 3LB, England
[3] Univ Glasgow, Adam Smith Business Sch, Main Bldg,Room G683,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland
[4] Univ Bath, Sch Management, Wessex House,Room 9-52, Bath BA2 7AY, Avon, England
来源
BRITISH ACCOUNTING REVIEW | 2019年 / 51卷 / 05期
关键词
R&D; IFRS; Corruption; Accounting choice; Future performance; Internationalization; VALUE-RELEVANCE; EARNINGS MANAGEMENT; UNITED-STATES; DEVELOPMENT EXPENDITURES; ECONOMIC CONSEQUENCES; CULTURE; FIRMS; INTANGIBLES; INTEGRATION; COMMITMENT;
D O I
10.1016/j.bar.2019.02.003
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
International Accounting Standard 38 Intangible Assets mandates that development costs must be capitalized if certain conditions specified in the standard are met. However, this requires managerial judgement and hence may be subject to opportunism. Corruption is a permeable informal country characteristic that penetrates firms' behaviour, influencing corporate misconduct. We conjecture that an environment with high corruption facilitates management in their justification of meeting the capitalization criteria of assets that should have been expensed, either partly or entirely. These capitalized assets will not generate the future economic benefits implicitly conveyed by their recognition. This recognition, however, sends positive (albeit distorted) market signals for future earnings and increases current year reported earnings. We find that there is a positive relation between country-level corruption and the amount of development costs capitalized in a given year. Moreover, the higher the levels of country corruption, the lower the contribution of capitalized development costs in a given year to future profitability. Finally, this association is moderated by companies' levels of internationalization. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页数:25
相关论文
共 50 条
  • [1] The impact of country-level corporate governance on research and development
    Hillier, David
    Pindado, Julio
    de Queiroz, Valdoceu
    de la Torre, Chabela
    [J]. JOURNAL OF INTERNATIONAL BUSINESS STUDIES, 2011, 42 (01) : 76 - 98
  • [2] The impact of country-level corporate governance on research and development
    David Hillier
    Julio Pindado
    Valdoceu de Queiroz
    Chabela de la Torre
    [J]. Journal of International Business Studies, 2011, 42 : 76 - 98
  • [3] The Influence of Country-Level Religiosity on Accounting Conservatism
    Bjornsen, Matt
    Do, Chuong
    Omer, Thomas C.
    [J]. JOURNAL OF INTERNATIONAL ACCOUNTING RESEARCH, 2019, 18 (01) : 1 - 26
  • [4] Country-level Accounting Enforcement and IPO Underpricing
    Bigus, Jochen
    Dreyer, Florian
    [J]. ABACUS-A JOURNAL OF ACCOUNTING FINANCE AND BUSINESS STUDIES, 2023, 59 (03): : 735 - 775
  • [5] Country-Level Environmental Performance: Investment, Education, and Research and Development
    Leyva-Hernandez, Sandra Nelly
    Teran-Bustamante, Antonia
    [J]. SOCIAL SCIENCES-BASEL, 2024, 13 (03):
  • [6] Altmetrics for Country-Level Research Assessment
    Alhoori, Hamed
    Furuta, Richard
    Tabet, Myrna
    Samaka, Mohammed
    Fox, Edward A.
    [J]. EMERGENCE OF DIGITAL LIBRARIES - RESEARCH AND PRACTICES, 2014, 8839 : 59 - 64
  • [7] Country-level governance, accounting standards, and tax avoidance: a cross-country study
    Zeng, Tao
    [J]. ASIAN REVIEW OF ACCOUNTING, 2019, 27 (03) : 401 - 424
  • [8] Assessing country-level efforts to link research to action
    Lavis, John N.
    Lomas, Jonathan
    Hamid, Maimunah
    Sewankambo, Nelson K.
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2006, 84 (08) : 620 - 628
  • [9] Collaboration in pharmaceutical research: exploration of country-level determinants
    Plotnikova, Tatiana
    Rake, Bastian
    [J]. SCIENTOMETRICS, 2014, 98 (02) : 1173 - 1202
  • [10] Collaboration in pharmaceutical research: exploration of country-level determinants
    Tatiana Plotnikova
    Bastian Rake
    [J]. Scientometrics, 2014, 98 : 1173 - 1202